UpcomingPDUFA target action date

Ulixacaltamide

Praxis Precision Medicines (PRAX)

Marketer take

Essential tremor is a large neurology and primary-care population, so this would be a broad-reach launch compared with most rare-disease decisions.

Sponsor company
Praxis Precision Medicines (PRAX)
Indication
Essential tremor
Therapeutic area
Neurology
Event
PDUFA target action date
Date
Jan 29, 2027
Status
Upcoming
Source
company press release
Last verified
Nov 15, 2026

Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?

Get alerts when FDA dates move